Aesthetic Medicine

LATEST NEWS

Botulinum Toxin May Be Beneficial for Androgenetic Alopecia

By

Colby Stong

Injectable botulinum toxin as a possible adjuvant treatment for patients with androgenetic alopecia was investigated.

Botulinum Toxin Use Associated With Improvements in Depression

By

Brandon May

Can use of botulinum toxin injection improve severity in patients with depression?

Ice Pack Compression, Vibration Anesthesia Device Reduce Pain During Scalp Injections

By

Colby Stong

Inexpensive, practical, and safe strategies to reduce patients’ pain level during inactivated PRP scalp injections are reviewed.

Single-Use Mineral Face Mask Improves Erythema, Quality of Life After Nonablative Laser Procedure

By

Colby Stong

The efficacy, tolerance, patient satisfaction, and quality of life of patients treated with the M89M mask after laser treatment was assessed.

Rapid Relief Restoring Cream Added to AmLactin Product Line

By

Brian Park, PharmD

AmLactin® Rapid Relief Restoring Cream is supplied in 12-ounce (340g) jars and costs $24.99.

Comparing Site Preparation Methods for the Surgical Treatment of Vitiligo

By

Emily Pond

The efficacy of recipient site preparation using dermabrasion, cryoblister, and dermaroller followed by NCES in stable vitiligo were compared.

Update: Facial Filler Use Now Reported by Moderna COVID-19 Vaccine Trial Participants

By

Heidi W. Moore

Moderna mRNA-1273-P301 study participants will now be asked to disclose information about their use of facial fillers.

Chemical Peels for the Treatment of Melasma in Patients of Color

By

Emily Pond

The study’s goal was to compare the clinical efficacy, safety, tolerability, and improvement in QOL index of three peeling agents for patients with melasma.

Fewer Occlusions for Facial Filler Injected With Cannulas Than With Needles

By

Colby Stong

Researchers sought to answer the question: “When injecting fillers, what is the risk of vascular occlusion with needles vs cannulas?”

Restylane Defyne Approved for Chin Augmentation

By

Brian Park, PharmD

Results showed that 74% of Restylane Defyne-treated patients achieved significantly improved chin projection for up to 1 year.